Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age

AIDS

Volumn 14, Issue 4, 2000, Pages 453-459

  Taha, Taha E ^a   Kumwenda, Newton I ^a   Hoover, Donald R ^a   Biggar, Robert J ^b   Broadhead, Robin L ^c   Cassol, Sharon ^d   Van der Hoven, Len ^a   Markakis, Diane ^a   Liomba, George N ^c   Chiphangwi, John D ^c   Miotti, Paolo G ^a,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MALAWI   (Malawi)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CD4 lymphocyte; Children; HIV; Mortality; Perinatal HIV infection; Viral load

Indexed keywords

CD4 ANTIGEN;

ARTICLE; CELL COUNT; CHILDHOOD MORTALITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTH AFRICA; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALAWI; MALE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 0034027031     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200003100-00021     Document Type: Article

References (19)

1. 1. Mofenson LM, Korelitz J, Meyer WA, et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. J Infect Dis 1997, 175: 1029-1038.
2. 2. Valentine ME, Jackson CR, Vavro C, et al. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six pediatric patients. Pediatr Infect Dis J 1998, 17:18-23.
3. 3. Abrams EJ, Weedon J, Steketee RW, et al. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. J Infect Dis 1998, 178:101-108.
4. 4. Palumbo PE, Raskino C, Fiscus S, et al. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA 1998, 279:756-761.
5. 5. Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996, 347:1647-1650.
6. 6. Biggar RJ, Miles W, Miotti PG, et al. Blood collection on filter paper: a practical approach to sample collection for large epidemiologic studies. J Acquired Immune Defic Syndr 1997, 14:368-373.
7. 7. Romano J, Shurtliff MC, Sarngadharan MG, Pal R. Detection of HIV-1 infection in vitro using NASBA: an isothermal RNA amplification technique. J Virol Methods 1995, 54:109-119.
8. 8. Cassol S, Gill MJ, Pilon R, et al. Quantification of HIV-1 RNA from dried blood spots collected on filter paper. J Clin Microbiol 1997, 35:2795-2801.
9. 9. Biggar RJ, Janes M, Pilon R, et al. Virus levels in untreated African infants infected with human immunodeficiency virus type 1. J Infect Dis 1999, 180:1838-1843.
10. 10. Bishop K, Kiepiela P, Dwarika S, et al. An evaluation of field technologies for the diagnosis of pediatric HIV-1 infection in South Africa. 2nd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, 1-6 September 1999 [Abstract 240].
11. 11. Dyer JR, Kazembe P, Vernazza PL, et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis 1998, 177: 1742-1746.
12. 12. Comeau AM, Su X, Gerstel J, et al. Use of microsample dried blood spot RNA for diagnosis of pediatric HIV in the first week of life. 5th Conference on Retroviruses and Opportunistic Infections. Chicago, 1-5 February 1998 [Abstract 530].
13. 13. Cassol S, Pilon R, Cormier M, et al. Dried blood spots for monitoring HIV-1 RNA load in neonates and infants. 5th Conference on Retroviruses and Opportunistic Infections. Chicago, 1-5 February 1998 [Abstract 315].
14. 14. Miotti PG, Liomba G, Dallabetta GA, et al. T-Iymphocyte subsets during and after pregnancy: analysis in human immunodeficiency virus type 1-infected and -uninfected Malawian mothers. J Infect Dis 1992, 163:1116-1119.
15. 15. Centers for Disease Control and Prevention. 1995 Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 1995, 44:1-11.
16. 16. Centers for Disease Control and Prevention. 1994 Revised classification systems for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, 43: 1-19.
17. 17. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N Engl J Med 1997, 336:1337-1342.
18. 18. Kalish LA, McIntosh K, Read J, et al. Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-infected children. J Infect Dis 1999, 180:1514-1520.
19. 19. Li-Hua P, Nelson JAE, Hoffman IF, et al. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol 1999, 73:6271-6281.